The report package Vaccine Markets in Western Europe to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in different Western European countries.
The package includes country reports from the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom
The research includes historical data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
The reports help answer the following questions: - What is the size of the vaccine market in different Western European countries? - How is the market split into different types of vaccines? - How are the overall market and different product types growing? - How is the market predicted to develop in the future?
The latest industry data included in the reports: - Demand for vaccines, 2011-2022 - Vaccine market size by product type, 2011-2022 - Growth rates of the overall market and different product segments, 2011-2022 - Shares of different product segments of the overall market, 2011, 2017, and 2022
The market data is given for the following product segments: Human vaccines Veterinary vaccines
Among the key reasons to purchase include the following: - Gain an outlook of the historical development, current market situation, and future outlook of the vaccine market in different Western European countries to 2022 - Track industry developments and identify market opportunities - Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects - Save time and money with the readily accessible key market data included in the reports. The data is clearly presented and can be easily incorporated into presentations and internal reports.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Jul 2020
Major players in the COVID19 vaccine and therapeutics clinical trial analysis market are Pfizer, GlaxoSmithKline (GSK), Inovio Pharmaceuticals, Johnson & Johnson (J&J), Novavax Inc., Heat Biologics, Sanofi, BioNTech, Vaxart, and Vir Biotechnology. The urgent need to develop vaccines or therapeutics in response to the outbreak of the...
Tularaemia - Pipeline Review, H1 2020
This latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia – Pipeline Review, H1 2020, provides an overview of the Tularaemia (Infectious Disease) pipeline landscape.
Tularaemia is an infection caused due to a bacterium called...
The global skin cancer diagnostics and therapeutics market are expected to witness a CAGR of 10.4% over the forecast period. Certain factors driving the market growth include increasing incidence of skin cancer, extensive R&D pipelines, and rising awareness about skin cancer.
Skin cancer is the...
Baculoviral IAP Repeat Containing Protein 5 - Pipeline Review, H2 2019 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) pipeline Target constitutes close to 20 molecules. Out of which approximately 14 molecules are developed by companies...
Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides.The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and anti-drug-antibodies...
Summary NBE-Therapeutics AG (NBE-Therapeutics) is a biotechnology company that focuses on the development of antibody drug conjugates (ADC) to improve the treatment of cancer.ADCs act against cancer cells via tumor-specific antibodies and deliver powerful cellular toxins to such cancer cells. The company develops...
Biological Safety Testing Market Size, Share & Trends Analysis Report By Product, By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test, By Region, And Segment Forecasts, 2018 - 2024
The global biological safety testing market size is expected to reach USD 5.54 billion by 2024 registering a CAGR of 12.2% during...
Report Scope: This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is global, with emphasis on U.S. and European data. The report identifies markets in general segments:...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.